Atlas Trials

Phenotyping of High Dose Rifampicin

Clinical trial NCT04525235 · COMPLETED

Trial details

NCT number
NCT04525235
Sponsor
Radboud University Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Tuberculosis
Start date
2021-01-07
Primary completion
2021-08-12
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.